Stock listing
NASDAQ:RNAZ TransCode Therapeutics, Inc. Stock
Home listing (NASDAQ) of TransCode Therapeutics, Inc.
Follow TransCode Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:RNAZ
$1.63 USD -0.10 (-5.8%)
Close on Oct 30, 2026
- Day range
- $1.62 – $1.79 USDOct 30, 2026
- Volume
- 16,185 sharesOct 30, 2026
- Market cap
- $27.60M USDAt the close on Oct 30, 2026 · price × 16.93M shares outstanding
- 52-week range
- $1.52 – $12.60 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $114,603 USDMedian day 28,837 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RNAZ · Home | $1.63 USD | -0.10 (-5.8%) | 16,185 | $1.73 | $1.785 | $1.62 | $1.73 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:RNAZ · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.63 | -0.10 | -5.8% | $1.73 | $1.785 | $1.62 | 16,185 | |
| $1.73 | -0.01 | -0.6% | $1.837 | $1.91 | $1.73 | 39,291 | |
| $1.74 | +0.07 | +4.2% | $1.61 | $1.78 | $1.61 | 18,493 | |
| $1.67 | -0.036 | -2.1% | $1.71 | $1.77 | $1.65 | 7,502 | |
| $1.706 | -0.065 | -3.6% | $1.78 | $1.78 | $1.70 | 54,290 | |
| $1.77 | +0.055 | +3.2% | $1.65 | $1.84 | $1.65 | 32,683 | |
| $1.715 | +0.055 | +3.3% | $1.62 | $1.80 | $1.62 | 27,965 | |
| $1.66 | -0.02 | -1.2% | $1.69 | $1.81 | $1.65 | 16,753 | |
| $1.68 | -0.02 | -1.2% | $1.71 | $1.75 | $1.603 | 20,230 | |
| $1.70 | 0.00 | 0.0% | $1.70 | $1.84 | $1.66 | 29,305 | |
| $1.70 | -0.10 | -5.6% | $1.83 | $1.864 | $1.695 | 29,017 | |
| $1.80 | +0.07 | +4.0% | $1.79 | $1.90 | $1.71 | 35,314 | |
| $1.73 | +0.05 | +3.0% | $1.74 | $1.82 | $1.67 | 43,235 | |
| $1.68 | +0.05 | +3.1% | $1.67 | $1.78 | $1.668 | 54,452 | |
| $1.63 | -0.23 | -12.4% | $1.91 | $1.91 | $1.63 | 31,932 | |
| $1.86 | +0.15 | +8.8% | $1.78 | $1.95 | $1.74 | 84,076 | |
| $1.71 | -0.05 | -2.8% | $1.80 | $1.80 | $1.675 | 27,836 | |
| $1.76 | -0.02 | -1.1% | $1.78 | $1.79 | $1.67 | 29,763 | |
| $1.78 | +0.02 | +1.1% | $1.77 | $1.815 | $1.71 | 47,336 | |
| $1.76 | +0.19 | +12.1% | $1.65 | $1.87 | $1.57 | 65,725 | |
| $1.57 | +0.025 | +1.6% | $1.58 | $1.66 | $1.545 | 15,503 | |
| $1.545 | -0.135 | -8.0% | $1.673 | $1.74 | $1.52 | 16,712 | |
| $1.68 | +0.05 | +3.1% | $1.748 | $1.748 | $1.64 | 6,733 | |
| $1.63 | -0.08 | -4.7% | $1.73 | $1.81 | $1.60 | 11,006 | |
| $1.71 | +0.02 | +1.2% | $1.71 | $1.79 | $1.63 | 40,680 | |
| $1.69 | +0.04 | +2.4% | $1.60 | $1.70 | $1.60 | 14,760 | |
| $1.65 | -0.03 | -1.8% | $1.62 | $1.74 | $1.62 | 28,656 | |
| $1.68 | -0.09 | -5.1% | $1.835 | $2.39 | $1.621 | 425,715 | |
| $1.77 | +0.01 | +0.6% | $1.87 | $1.911 | $1.707 | 59,514 | |
| $1.76 | +0.11 | +6.7% | $1.67 | $1.97 | $1.67 | 66,202 | |
| $1.65 | -0.07 | -4.1% | $2.00 | $2.00 | $1.65 | 30,904 | |
| $1.72 | +0.04 | +2.4% | $1.70 | $1.72 | $1.63 | 58,149 | |
| $1.68 | +0.08 | +5.0% | $1.66 | $1.71 | $1.579 | 18,698 | |
| $1.60 | -0.05 | -3.0% | $1.65 | $1.70 | $1.60 | 18,516 | |
| $1.65 | -0.04 | -2.4% | $1.65 | $1.72 | $1.65 | 20,663 | |
| $1.69 | 0.00 | 0.0% | $1.68 | $1.74 | $1.627 | 11,445 | |
| $1.69 | -0.09 | -5.1% | $1.72 | $1.83 | $1.69 | 26,085 | |
| $1.78 | -0.11 | -5.8% | $1.86 | $1.95 | $1.75 | 30,939 | |
| $1.89 | -0.17 | -8.3% | $1.98 | $2.03 | $1.88 | 37,786 | |
| $2.06 | -0.095 | -4.4% | $2.18 | $2.18 | $2.05 | 10,622 | |
| $2.155 | +0.145 | +7.2% | $2.27 | $2.27 | $2.02 | 69,966 | |
| $2.01 | -0.05 | -2.4% | $2.06 | $2.12 | $2.01 | 22,514 | |
| $2.06 | -0.04 | -1.9% | $2.08 | $2.35 | $2.04 | 98,170 | |
| $2.10 | -0.08 | -3.7% | $2.10 | $2.28 | $1.832 | 838,250 | |
| $2.18 | -0.10 | -4.4% | $2.24 | $2.345 | $2.09 | 38,032 | |
| $2.28 | -0.06 | -2.6% | $2.35 | $2.409 | $2.27 | 27,617 | |
| $2.34 | -0.19 | -7.5% | $2.58 | $2.58 | $2.24 | 24,254 | |
| $2.53 | -0.17 | -6.3% | $2.74 | $2.873 | $2.40 | 138,123 | |
| $2.70 | -0.17 | -5.9% | $2.90 | $2.91 | $2.65 | 78,327 | |
| $2.87 | -0.10 | -3.4% | $2.90 | $3.00 | $2.87 | 42,178 | |
| $2.97 | -0.24 | -7.5% | $3.121 | $3.28 | $2.87 | 45,694 | |
| $3.21 | -0.03 | -0.9% | $3.27 | $3.49 | $3.03 | 76,126 | |
| $3.24 | +0.08 | +2.5% | $3.00 | $3.37 | $3.00 | 22,063 | |
| $3.16 | -0.12 | -3.7% | $3.36 | $3.498 | $2.943 | 81,257 | |
| $3.28 | -0.20 | -5.7% | $3.50 | $3.70 | $3.21 | 41,008 | |
| $3.48 | +0.11 | +3.3% | $3.42 | $3.50 | $3.30 | 23,982 | |
| $3.37 | -0.06 | -1.7% | $3.40 | $3.61 | $3.32 | 21,581 | |
| $3.43 | -0.45 | -11.6% | $3.90 | $3.98 | $3.43 | 24,118 | |
| $3.88 | -0.08 | -2.0% | $3.91 | $4.26 | $3.88 | 20,135 | |
| $3.96 | -0.31 | -7.3% | $4.00 | $4.31 | $3.96 | 28,588 | |
| $4.27 | +0.02 | +0.5% | $4.30 | $4.30 | $3.99 | 13,385 | |
| $4.25 | -0.20 | -4.5% | $4.54 | $4.54 | $4.25 | 8,373 | |
| $4.45 | +0.23 | +5.5% | $4.38 | $4.72 | $4.38 | 14,482 | |
| $4.22 | -0.34 | -7.5% | $4.521 | $4.62 | $4.22 | 10,714 | |
| $4.56 | -0.69 | -13.1% | $5.13 | $5.37 | $4.47 | 30,263 | |
| $5.25 | +0.29 | +5.8% | $5.06 | $5.505 | $5.001 | 10,347 |
- Ticker
- NASDAQ:RNAZ
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
TransCode Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process Intended to Maximize Value of TTX-MC138 and its Oncology Portfolio
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 44 slides
Latest news
TransCode Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process Intended to Maximize Value of TTX-MC138 and its Oncology Portfolio
Oct 28, 2026
Closed $1.73 (-0.6%) on Oct 29, 2026
TransCode Therapeutics Presents Phase 1a Clinical Data for TTX-MC138 at ESMO Congress 2026
Oct 26, 2026
Closed $1.71 (-3.6%) on Oct 26, 2026
TransCode Therapeutics to Present Phase 1a Clinical Trial Data for TTX-MC138 at ESMO Congress 2026
Oct 19, 2026
Closed $1.70 (0.0%) on Oct 19, 2026
Natera and TransCode Therapeutics to Collaborate on Phase 2a Trial of TTX-MC138 in Colorectal Cancer
Oct 13, 2026
Closed $1.68 (+3.1%) on Oct 13, 2026
TransCode Reports Continued Disease Stabilization and Extended Treatment Duration with TTX-MC138 in Ongoing Phase 1a Clinical Trial Follow-Up
Sep 28, 2026
Closed $1.71 (+1.2%) on Sep 28, 2026
TransCode Therapeutics Announces Patent Advancements in Australia and Japan Strengthening Global IP Position in RNA-Based Immuno-Oncology
Sep 22, 2026
Closed $1.77 (+0.6%) on Sep 22, 2026
TransCode Therapeutics Announces Leadership Transition
Sep 10, 2026
Closed $1.69 (0.0%) on Sep 11, 2026
TransCode Therapeutics Announces Publication Demonstrating Survival Benefit of TTX-MC138 in Preclinical Model of Breast Cancer Bone Metastasis
Aug 31, 2026
Closed $2.10 (-3.7%) on Aug 31, 2026
TransCode Therapeutics to Host R&D Webcast on June 18, 2026
Jun 8, 2026
Closed $5.09 (-9.1%) on Jun 8, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 44 slides · September 2026
Investor Presentation (June 2026)
Investor deck · 44 slides · Jun 18, 2026
Investor Presentation (December 2025)
Investor deck · 28 slides · Dec 18, 2025
Investor Presentation (October 2025)
Investor deck · 35 slides · Oct 8, 2025
TransCode Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 113 in all · newest Oct 28, 2026 · oldest 2021
- Decks
- 6 decks · latest September 2026
Where TransCode Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RNAZ · Home listing · This page | NASDAQ | United States | USD |
| BOATS:RNAZ | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about TransCode Therapeutics, Inc.